Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

Gooptu Mahasweta; Kim Haesook T.; Howard Alan; Choi Sung W.; Soiffer Robert J.; Antin Joseph H.; Ritz Jerome; Cutler Corey S.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

【24h】

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

机译：西罗司对霉菌同种异体干细胞移植后免疫重建的影响：随机对照试验与甲酮/甲氨蝶呤/甲氨蝶呤（BMT CTN 0402）进行随机对照试验的术后分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Gooptu Mahasweta; Kim Haesook T.; Howard Alan; Choi Sung W.; Soiffer Robert J.; Antin Joseph H.; Ritz Jerome; Cutler Corey S.;
展开▼
作者单位

Dana Farber Canc Inst Div Hematol Malignancies Boston MA 02115 USA;

Dana Farber Canc Inst Dept Biostat &

Computat Biol Boston MA 02115 USA;

Ctr Int Blood &

Marrow Transplant Res Minneapolis MN USA;

Univ Michigan Hlth Syst Ann Arbor MI USA;

Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

Dana Farber Canc Inst Div Hematol Malignancies Boston MA 02115 USA;

Harvard Med Sch Dana Farber Boston Childrens Canc &

Blood Disorde Boston MA USA;

Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献

1. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402) [J] . Gooptu Mahasweta, Kim Haesook T., Howard Alan, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：西罗司对霉菌同种异体干细胞移植后免疫重建的影响：随机对照试验与甲酮/甲氨蝶呤/甲氨蝶呤（BMT CTN 0402）进行随机对照试验的术后分析
2. Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. [J] . Ho VT, Aldridge J, Kim HT Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2009,第7期

机译：在降低强度的同种异体外周血干细胞移植后，他克莫司和西罗莫司（Tac / Sir）与他克莫司，西罗莫司和小型甲氨蝶呤（Tac / Sir / MTX）作为急性移植物抗宿主病预防的比较。
3. Angiogenic Factors, Inflammation, and Outcomes in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Biomarker Analysis of Gvhd Prophylaxis in Blood and Marrow Transplant Clinical Trials Network Protocol (BMT CTN) 0402 [J] . Newell Laura F., Verneris Michael R., Panoskaltsis-Mortari Angela, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：异基因异基因造血细胞移植的血管生成因子，炎症和结果：血液和骨髓移植临床试验网络协议（BMT CTN）0402中预防Gvhd的生物标志物分析
4. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation [O] . Johan Törlén, Olle Ringdén, Karin Garming-Legert, 2016

机译：比较环孢素/甲氨蝶呤和他克莫司/西罗莫司作为异基因造血干细胞移植后移植物抗宿主病预防的一项前瞻性随机试验
5. Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation [O] . Ho Vincent T., Aldridge Julie, Kim Haesook T., 2009

机译：他克莫司和西罗莫司（Tac / Sir）与他克莫司，西罗莫司和小型甲氨蝶呤（Tac / Sir / MTX）作为强度降低的异体异体外周血干细胞移植后急性移植物抗宿主病预防的比较

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

著录项

相似文献

相关主题

期刊订阅